相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In Vivo MRI Stem Cell Tracking Requires Balancing of Detection Limit and Cell Viability
K. Nohroudi et al.
CELL TRANSPLANTATION (2010)
Mesenchymal Stem Cells: Mechanisms of Immunomodulation and Homing
Hiroshi Yagi et al.
CELL TRANSPLANTATION (2010)
Mesenchymal stromal cells transiently alter the inflammatory milieu post-transplant to delay graft-versus-host disease
Melinda E. Christensen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group
Mark S. Freedman et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Strategies to Rescue Mesenchymal Stem Cells (MSCs) and Dental Pulp Stem Cells (DPSCs) from NK Cell Mediated Cytotoxicity
Anahid Jewett et al.
PLOS ONE (2010)
Interferon-γ and Tumor Necrosis Factor-α Differentially Affect Cytokine Expression and Migration Properties of Mesenchymal Stem Cells
Hatim Hemeda et al.
STEM CELLS AND DEVELOPMENT (2010)
Advancement of Mesenchymal Stem Cell Therapy in Solid Organ Transplantation (MISOT)
Martin J. Hoogduijn et al.
TRANSPLANTATION (2010)
Mesenchymal stromal cells promote or suppress the proliferation of T lymphocytes from cord blood and peripheral blood: the importance of low cell ratio and role of interleukin-6
Mehdi Najar et al.
CYTOTHERAPY (2009)
Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and-9
Yunchuan Ding et al.
DIABETES (2009)
Adipose-Derived Mesenchymal Stem Cells Alleviate Experimental Colitis by Inhibiting Inflammatory and Autoimmune Responses
Manuel A. Gonzalez et al.
GASTROENTEROLOGY (2009)
Early modulation of inflammation by mesenchymal stem cell after acute kidney injury
Patricia Semedo et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
Paolo Fiorina et al.
JOURNAL OF IMMUNOLOGY (2009)
Brief Report-Human Embryonic Stem Cell-Derived Mesenchymal Progenitors Possess Strong Immunosuppressive Effects Toward Natural Killer Cells as Well as T Lymphocytes
B. Linju Yen et al.
STEM CELLS (2009)
Donor-Derived Mesenchymal Stem Cells Suppress Alloreactivity of Kidney Transplant Patients
Meindert J. Crop et al.
TRANSPLANTATION (2009)
Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group
Marc H. Dahlke et al.
TRANSPLANTATION (2009)
The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes
Soraya Tabera et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells
Federica Casiraghi et al.
JOURNAL OF IMMUNOLOGY (2008)
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease:: a phase II study
Katarina LeBlanc et al.
LANCET (2008)
Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice
Marina Morigi et al.
STEM CELLS (2008)
Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4(+)CD25(high)FOXP3(+) regulatory T cells
Zohair Selmani et al.
STEM CELLS (2008)
Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2
Grazia Maria Spaggiari et al.
BLOOD (2008)
Human heart, spleen, and perirenal fat-derived mesenchymal stem cells have immunomodulatory capacities
M. J. Hoogduijn et al.
STEM CELLS AND DEVELOPMENT (2007)
Murine bone marrow stromal progenitor cells elicit an in vivo cellular and humoral alloimmune response
Andrea T. Badillo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting
Alma J. Nauta et al.
BLOOD (2006)
Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation
GM Spaggiari et al.
BLOOD (2006)
Role for interferon-γ in the immunomodulatory activity of human bone marrow mesenchymal stem cells
Mauro Krampera et al.
STEM CELLS (2006)
Human mesenchymal stem cells modulate B-cell functions
A Corcione et al.
BLOOD (2006)
Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons
Kirstin J. Beggs et al.
CELL TRANSPLANTATION (2006)
Interactions between human mesenchymal stem cells and natural killer cells
PA Sotiropoulou et al.
STEM CELLS (2006)
Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice
N Eliopoulos et al.
BLOOD (2005)
Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms
F Tögel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Human mesenchymal stem cells modulate allogeneic immune cell responses
S Aggarwal et al.
BLOOD (2005)
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells
I Rasmusson et al.
TRANSPLANTATION (2003)
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli
M Di Nicola et al.
BLOOD (2002)
分享论文
